Interstitial Lung Disease Trial, Recruiting NCT07512687 Sponsor: State University of New York at Buffalo Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT07512687
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 85 years who have been diagnosed with fibrotic interstitial lung disease (a type of scarring lung condition) or COPD (a chronic lung condition that makes breathing difficult), and who are able to agree to take part in the study.
  • Fibrotic lung disease in this trial includes conditions such as idiopathic pulmonary fibrosis, sarcoidosis, or other lung conditions where scarring changes are visible on lung imaging.
  • People with COPD must have a specific type of breathing test result showing their airways are narrowed below a certain level, as measured by a standard COPD assessment tool.
  • People who are able to walk outside their home without using a walking aid such as a cane or walker (based on self-report).
  • People whose lung condition and medications have been stable for at least the three months before joining the trial.
  • People whose blood oxygen levels drop only during exercise (not at rest), specifically dropping to 89% or below for at least 10 seconds during a standard six-minute walk test while breathing normal air.
  • People who are able to keep their blood oxygen level at 89% or above for the full six-minute walk test while using two specific types of portable oxygen devices at moderate flow settings.

Who may not be able to join:

  • People younger than 18 or older than 85 years of age.
  • People who have been diagnosed with both fibrotic lung disease and COPD at the same time.
  • People whose blood oxygen level is already low (below 89%) while resting and breathing normal air.
  • People who have visited an emergency room or been admitted to hospital in the three months before joining the trial.
  • People whose medications were changed in the three months before joining the trial.
  • People who need a walking aid such as a cane or walker to move around.
  • People who are pregnant.
  • People who currently smoke, or who live with someone who currently smokes.
  • People who are currently taking part in a pulmonary rehabilitation program.
  • People who do not have a smartphone that works with a specific app called Oxiwear, or who have a compatible phone but do not have home wifi or a mobile data plan that would allow the app to upload health data.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristopher Clark, MD, State University of Buffalo Jacobs School of Medicine and Biomedical Sciences

Phone: 7168591516

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
State University of New York at Buffalo
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Steps Per Day

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov